GUEST EDITORIAL
From Littleton, Colorado, I write to tell you that this community is contorted with grief. Complacency is no longer an option. Recognize that we have a problem. Recognize that this killing will happen again, perhaps to your child, before we find the means and the will to make it stop. And then act on that recognition, that our suffering will not have been in vain.
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Andrew Alexis, MD, MPH, highlights positive lebrikizumab-lbkz data for atopic dermatitis
June 25th 2025Lebrikizumab demonstrated efficacy and safety in patients with skin of color and moderate-to-severe atopic dermatitis in the ADmirable trial. Trial investigator Andrew Alexis, MD, MPH, reacts.
